Genocea Biosciences, Inc. filed its 10-K on Mar 18, 2022 for the period ending Dec 31, 2021. In this report its auditor, Ernst & Young LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | -.--% | -.--% | -99.00% |
2023 | Genocea Biosciences, Inc. Went Out of Business | CI |
2023 | Liquidation Plan Approved for Genocea Biosciences, Inc. | CI |
1st Jan change | Capi. | |
---|---|---|
-99.00% | 58 | |
+26.28% | 48.09B | |
-3.99% | 40.43B | |
+47.07% | 40.62B | |
-6.20% | 28.36B | |
+6.36% | 24.89B | |
-21.47% | 19.01B | |
+27.58% | 12.09B | |
-2.75% | 11.8B | |
-2.02% | 11.88B |
- Stock Market
- Equities
- GNCAQ Stock
- News Genocea Biosciences, Inc.
- Genocea Biosciences, Inc. Auditor Raises 'Going Concern' Doubt